Optimal treatment of dyslipidemia in high-risk patients: intensive statin treatment or combination therapy?

about

Optimal treatment of dyslipidemia in high-risk patients: intensive statin treatment or combination therapy?

Item

http://www.wikidata.org/entity/Q36704251

description

2007 nî lūn-bûn

@nan

2007年の論文

@ja

2007年論文

@yue

2007年論文

@zh-hant

2007年論文

@zh-hk

2007年論文

@zh-mo

2007年論文

@zh-tw

2007年论文

@wuu

2007年论文

@zh

2007年论文

@zh-cn

name

Optimal treatment of dyslipide ...... atment or combination therapy?

@ast

Optimal treatment of dyslipide ...... atment or combination therapy?

@en

type

Item

label

Optimal treatment of dyslipide ...... atment or combination therapy?

@ast

Optimal treatment of dyslipide ...... atment or combination therapy?

@en

prefLabel

Optimal treatment of dyslipide ...... atment or combination therapy?

@ast

Optimal treatment of dyslipide ...... atment or combination therapy?

@en

P1476

Optimal treatment of dyslipide ...... atment or combination therapy?

@en

P2093

Michael Miller

http://www.w3.org/2001/XMLSchema#string

P2860

MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20,536 high-risk individuals: a randomised placebo-controlled trial

Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III guidelines

Intensive versus moderate lipid lowering with statins after acute coronary syndromes

Prevention of coronary and stroke events with atorvastatin in hypertensive patients who have average or lower-than-average cholesterol concentrations, in the Anglo-Scandinavian Cardiac Outcomes Trial--Lipid Lowering Arm (ASCOT-LLA): a multicentre ra

Effect of very high-intensity statin therapy on regression of coronary atherosclerosis: the ASTEROID trial.

Factors associated with low compliance with lipid-lowering drugs in hyperlipidemic patients.

Sex bias and underutilization of lipid-lowering therapy in patients with coronary artery disease at academic medical centers in the United States and Canada. Prospective Randomized Evaluation of the Vascular Effects of Norvasc Trial (PREVENT) Invest

The lipid treatment assessment project (L-TAP): a multicenter survey to evaluate the percentages of dyslipidemic patients receiving lipid-lowering therapy and achieving low-density lipoprotein cholesterol goals.

Effectiveness of statin titration on low-density lipoprotein cholesterol goal attainment in patients at high risk of atherogenic events.

Achieving and maintaining National Cholesterol Education Program low-density lipoprotein cholesterol goals with five statins.

P304

31-35

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1111/J.1520-037X.2007.05662.X

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2007-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

17215631

http://www.w3.org/2001/XMLSchema#string

P921

dyslipidemias